Effects of a Carbonated Water Enriched With Amino Acids and Chromium Picolinate (Good Idea®) on Glucose Homeostasis.
A Randomized, Double-blind, Placebo-controlled, Crossover, Single-center, Proof of Concept Study to Evaluate the Efficacy of GoodIdea® on Glucose Homeostasis in a Healthy Population.
1 other identifier
interventional
44
1 country
1
Brief Summary
It has previously been shown in healthy subjects, that a carbonated water containing a mix of amino acids and chromium picolinate can decrease postprandial blood glucose. Based on these findings, a flavored sparkling water product called Good Idea® with a proprietary blend of five amino acids and chromium picolinate has been developed. This product, along with an identical placebo, are included in this study to evaluate the effects on postprandial blood glucose in healthy, overweight adults when consumed with a standardized, high glycemic test meal. The study will be conducted in a cross-over design, double-blinded and placebo controlled, including 45 participants. The primary endpoint of the study is the incremental area under the curve (iAUC) for capillary blood glucose within 180 minutes after ingestion of the meal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2018
CompletedStudy Start
First participant enrolled
April 24, 2018
CompletedFirst Posted
Study publicly available on registry
June 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2018
CompletedSeptember 4, 2019
September 1, 2019
4 months
April 23, 2018
September 2, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
The three-hour incremental area under the curve (iAUC) for capillary blood glucose, 0-180 minutes
The incremental area under the curve for capillary blood glucose will be measured within 180 minutes after a test meal. Blood samples will be collected at 8 time points during the 180 minutes.
0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal
Secondary Outcomes (3)
The three-hour iAUC for insulin, 0-180 minutes
0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal
The three hour iAUC for intravenous glucose, 0-180 minutes
0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal
The one-hour iAUC for intravenous Glucagon-like peptide 1 (GLP-1), 0-60 minutes
0, 15, 30, 45 and 60 minutes post test meal
Other Outcomes (6)
The three-hour Cmax of capillary blood glucose, venous blood glucose and venous blood insulin
0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal
The Tmax (time to maximum concentration) of capillary blood glucose, venous blood glucose and venous blood insulin
0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal
The two-hour iAUC for capillary blood glucose, venous blood glucose and venous blood insulin
0, 15, 30, 45, 60, 90 and 120 minutes post test meal
- +3 more other outcomes
Study Arms (2)
Water with amino acids and chromium
ACTIVE COMPARATORThe carbonated water with a proprietary blend of five amino acids and chromium picolinate is consumed with a standardized test meal to study its effects on glucose and insulin responses.
Carbonated water
PLACEBO COMPARATORThe placebo carbonated water is consumed with a standardized test meal to study its effects on glucose and insulin responses.
Interventions
The active carbonated water containing amino acids and chromium picolinate is consumed with a standardized test meal. Postprandial glucose and insulin response is documented for 180 minutes
The placebo carbonated water is consumed with a standardized test meal. Postprandial glucose and insulin response is documented for 180 minutes
Eligibility Criteria
You may qualify if:
- Male or female 18 to 50 years of age
- BMI 25-29.9 (±0.5) kg/m²
- Agree to maintain consistent dietary habits and physical activity levels for the duration of the study
- Healthy as determined by medical history and information provided by the volunteer
- Willingness to complete questionnaires and follow instructions associated with the study and to complete all visits
- Has given voluntary, written, informed consent to participate in the study
You may not qualify if:
- Elevated fasting blood glucose (at or above 6.1 mmol/L)
- Women who are pregnant or breast feeding
- Any medical condition(s) or medication(s) known to significantly affect glucose metabolism. Significance to be assessed by the QI
- Use of medication, over-the-counter medication, natural health products or dietary supplements/probiotics that may affect glucose metabolism is prohibited during this study. Significance to be assessed by the qualified investigator (QI). Participants who are taking allowed prescribed medications must agree to maintain their current method and dosing regimen during the course of the study unless recommended by their physician.
- Known Type I or Type II diabetes, including women who previously have had gestational diabetes.
- Use of antibiotics within 2 weeks of enrollment
- Metabolic diseases and/or chronic gastrointestinal diseases (IBS, Crohns etc.)
- Allergy to ingredients included in investigational product, placebo or standardized meal
- Participants restricted to a vegetarian or vegan diet
- Intolerance to lactose or gluten
- Individuals who are averse to venous catheterization or capillary blood sampling
- Currently active smokers (or using other tobacco products, and e-cigarettes)
- Unstable medical conditions as determined by QI
- Participation in other clinical research trials
- Individuals who are cognitively impaired and/or who are unable to give informed consent
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- DoubleGood ABlead
- Lund Universitycollaborator
Study Sites (1)
Dept Experimental Medical Science, Lund University
Lund, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristina E Andersson, PhD
Lund University and Aventure AB
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2018
First Posted
June 11, 2018
Study Start
April 24, 2018
Primary Completion
September 5, 2018
Study Completion
September 5, 2018
Last Updated
September 4, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share